News
Vektor Medical Rhythm Theater at HRS '25
Saturday, April 26th 9.15-10am, Rhythm Theater 2
AI and PFA: A Complementary Approach to Arrhythmia Treatment
Explore how vMap’s technology is redefining arrhythmia localization and treatment options. Our expert panel will highlight the impact of AI-powered ECG analysis on clinical workflows, accuracy in ablation procedures, and patient outcomes. Gain insights into the latest advancements, upcoming studies, and the growing role of AI in shaping the future of electrophysiology.
Visit Vektor’s Booths #1622 & #1523 (side-by-side) for a demo and to meet the team.
Computer-Based 12-Lead ECG Analysis Accurately Maps Ventricular Locations
Researchers, in an abstract and associated poster published in the Heart Rhythm Society’s journal Heart Rhythm, find that computer-based analysis of 12-lead ECG accurately mapped 93% of known ventricular locations to the exact ventricular segment. The computer-based analysis required only 3 minutes, plus or minus 2 minutes, per ECG.
Vektor Medical, Inc. Announces the Closing of Its Series Seed Funding Round to Support the Development and U.S. FDA Clearance of vMap™
Vektor Medical, Inc. is pleased to announce its Series Seed financing round is fully subscribed, and the round is officially closed. The investment round will enable Vektor to further invest in investigative research, efforts toward U.S. Food and Drug Administration 510(K) clearance, and development of a commercial product. “With the support of our investors, we are delighted to have successfully closed this funding round in less than two months and with more investor interest than we had room for in the round.” Rob Krummen, COO and General Counsel
12-Lead ECG-Based Mapping Guides Non-Invasive Radiation Therapy
In an abstract published in the American Heart Association’s journal, Circulation, researchers conclude that a case of stereotactic radioablation of ventricular tachycardia illustrates efficacy of non-invasive 12-lead ECG mapping and radioablation in a patient who failed prior invasive VT therapies.
Computerized Mapping Enables New Procedure for Ventricular Fibrillation
A new procedure developed at UC San Diego Health uses targeted ablation to enable treatment for ventricular fibrillation. The procedure is enabled by the use of electrocardiograms to make a computerized map of the heart’s own voltage.
Vektor Medical, Inc. Successfully Closes Its Convertible Note Funding Round
Today, Vektor Medical, Inc. announces the closing of its Convertible Note funding round. The funds will be used to support research relating to and development of a non-invasive computational arrhythmia mapping device. “We’re excited to welcome our investors on board and join Vektor’s journey in creating the next generation of arrhythmia mapping technology. This funding round enables us to build out our team and further research and develop the technology created by our UCSD founders”. Mike Monko, CEO & Co-Founder of Vektor Medical, Inc.